Belorgey Didier, Hägglöf Peter, Karlsson-Li Susanna, Lomas David A
Department of Medicine, University of Cambridge, Cambridge Institute for Medical Research, Cambridge, United Kingdom.
Prion. 2007 Jan-Mar;1(1):15-20. doi: 10.4161/pri.1.1.3974. Epub 2007 Jan 6.
The serpins are the largest superfamily of protease inhibitors. They are found in almost all branches of life including viruses, prokaryotes and eukaryotes. They inhibit their target protease by a unique mechanism that involves a large conformational transition and the translocation of the enzyme from the upper to the lower pole of the protein. This complex mechanism, and the involvement of serpins in important biological regulatory processes, makes them prone to mutation-related diseases. For example the polymerization of mutant alpha(1)-antitrypsin leads to the accumulation of ordered polymers within the endoplasmic reticulum of hepatocytes in association with cirrhosis. An identical process in the neuron specific serpin, neuroserpin, results in the accumulation of polymers in neurons and the dementia FENIB. In both cases there is a clear correlation between the molecular instability, the rate of polymer formation and the severity of disease. A similar process underlies the hepatic retention and plasma deficiency of antithrombin, C1 inhibitor, alpha(1)-antichymotrypsin and heparin co-factor II. The common mechanism of polymerization has allowed us to group these conditions together as a novel class of disease, the serpinopathies.
丝氨酸蛋白酶抑制剂(serpins)是最大的蛋白酶抑制剂超家族。它们存在于生命的几乎所有分支中,包括病毒、原核生物和真核生物。它们通过一种独特的机制抑制其靶蛋白酶,该机制涉及大的构象转变以及酶从蛋白质的上极到下极的移位。这种复杂的机制以及丝氨酸蛋白酶抑制剂参与重要的生物调节过程,使它们容易引发与突变相关的疾病。例如,突变型α1-抗胰蛋白酶的聚合导致有序聚合物在肝细胞内质网内积累,并伴有肝硬化。神经元特异性丝氨酸蛋白酶抑制剂神经丝氨酸蛋白酶中发生的相同过程,导致聚合物在神经元中积累以及痴呆症FENIB。在这两种情况下,分子不稳定性、聚合物形成速率与疾病严重程度之间都存在明显的相关性。抗凝血酶、C1抑制剂、α1-抗糜蛋白酶和肝素辅因子II的肝脏潴留和血浆缺乏也有类似的过程。聚合的共同机制使我们能够将这些病症归为一类新型疾病,即丝氨酸蛋白酶抑制剂病。